AI in Healthcare

Discover AI applications and innovations in healthcare

65 articles

Oracle Health Clinical AI Agent for Nurses Goes Live: Voice-Driven EHR Navigation, BayCare Early Adopter Saves 400,000 Hours of Documentation

Oracle Health launched its Clinical AI Agent for nurses on September 14, 2026, embedded directly into the EHR system with voice-driven navigation, acute nursing summaries, and voice-enabled discrete charting. BayCare Health System is an early adopter, and Oracle Health's previous AI tools have already saved physicians over 400,000 hours of documentation.

Sep 28, 20266

Anthropic's 950 Claude Agents Collaborate 21 Hours to Discover CRISPR-Like ART Enzyme System: New Milestone in AI-Driven Biological Discovery

Anthropic's swarm of 950 Claude AI agents collaborated for 21 hours, processing 210 million tokens and screening 200,000 candidates to discover the novel ART (Array-associated Reverse Transcriptases) enzyme system with CRISPR-like structural features, demonstrating AI agents' revolutionary potential in biomedical discovery.

Sep 27, 20266

ARPA-H Commits $62.7M to Build World's First FDA-Authorized Cardiovascular AI Agent

ARPA-H announced a $62.7 million, four-year ADVOCATE program to develop the world's first FDA-authorized autonomous cardiovascular AI agent system, involving Atman Health, Tempus AI, Stanford, Duke University, and Kaiser Permanente, with projected annual savings of $28 billion.

Sep 26, 20267

Forus AI Prescription Management Platform Closes $150M Series C at $3B Valuation, AI Agents Reshape Healthcare Supply Chain

Healthcare AI startup Forus closed a $150M Series C at a $3B valuation, tripling in four months. Its core innovation assigns an AI agent to every prescription, reducing insurance prior authorization time from weeks to under 48 hours, covering all 50 U.S. states.

Sep 25, 20266

ARPA-H Commits $62.7M to ADVOCATE Program: World's First Patient-Facing Autonomous Clinical AI Agents for Heart Failure, FDA Authorization, Stanford Supervisory AI Architecture

ARPA-H announced the $62.7M ADVOCATE program on September 9, 2026, to develop the world's first patient-facing autonomous clinical AI agents for heart failure management. Six awardees include Kaiser Permanente, Duke, and Stanford, with FDA participating collaboratively throughout and Stanford leading a supervisory AI architecture for safety.

Sep 22, 20268

Midjourney Enters Healthcare: Full-Body Ultrasound Scanner Generates 3D Maps in 60 Seconds, A New Chapter in AI Health Revolution

Midjourney established a medical division in June 2026, unveiling a full-body ultrasound scanner prototype that generates 3D body maps in 60 seconds. Using 40 Butterfly Network ultrasound chips, the device lacks FDA diagnostic clearance and plans to launch as 'body composition maps,' with a Midjourney Spa flagship experience center planned for San Francisco by late 2027.

Sep 20, 20268

ByteDance AI Drug Discovery Spinoff Anew Labs Closes $290M Debut Round: $1.5B Valuation, AnewFold Protein Prediction Leads, China AI Pharma Track Ignites Capital Frenzy

ByteDance's AI drug discovery unit Anew Labs closed its debut $290M external funding round on September 16, 2026, at a $1.5B valuation with ByteDance retaining 56% control. The company owns four core technologies: AnewFold, AnewSampling, AnewDesign, and AnewMind, led by HSG, IDG Capital, and Hillhouse.

Sep 19, 20267

Ambience Healthcare Launches 'Ambience Standard' Outcome-Based AI Partnership: 3x ROI, 92% Clinician Adoption, Physician Burnout Drops from 45% to 31% — Reshaping Healthcare AI Business Models

Ambience Healthcare launches outcome-based AI partnership 'Ambience Standard,' tying fees to verifiable clinical outcomes. Partner institutions achieve 3x ROI, 92% clinician adoption, and physician burnout drops from 45% to 31%, reshaping healthcare AI business models.

Sep 18, 20269

Assort Health Closes $120M Series C at $1.2B Unicorn Valuation: AI Patient Journey Agent Platform with Synapse Model Trained on 190M+ Interactions Tackles $1.1T Healthcare Admin Burden

Assort Health closed a $120M Series C in June 2026 at a $1.2B unicorn valuation. Its AI patient journey agent platform, powered by the Synapse model trained on 190M+ patient interactions and 62,000 care protocols, achieved 20x revenue growth in 15 months, targeting the $1.1T annual US healthcare administrative burden.

Sep 17, 20269

Tempus AI Launches Million Genome Initiative: Building First 100K Disease-Specific Whole Genome Dataset Linked to Longitudinal Clinical Outcomes, Advancing AI-Driven Precision Medicine Revolution

Tempus AI announced on September 11, 2026 the launch of a million genome initiative, with an initial target of 100,000 disease-specific whole genomes linked to longitudinal clinical outcomes, building a 'model-ready' AI research environment, with a long-term goal of 1 million genomes to advance AI-driven precision medicine.

Sep 16, 202610

FDB Script Agent Goes Commercial: Ambient AI Automates Prescription Generation, Revolutionizing Clinical Workflows

FDB's Script Agent achieved its first commercial deployment in August 2026, using ambient listening technology to automatically convert patient-clinician dialogue into structured prescriptions, integrated with FDB's clinically validated medication intelligence and EHR systems via MCP server.

Sep 15, 20269

FDA Releases Generative AI Medical Device Regulatory Discussion Paper: Two-Axis Risk Framework, Competency Evaluation Model, and Foundation Model Master File — Global AI Healthcare Regulation Milestone

The FDA released a generative AI medical device regulatory discussion paper on August 18, 2026, proposing a two-axis risk matrix (autonomy × consequence severity), a competency evaluation model inspired by medical training, a voluntary Foundation Model Device Master File (MAF), and a special review framework for agentic AI systems, with public comments open until October 19, 2026.

Sep 14, 20269

PreviousPage 4 / 6Next